Adipocyte is a non-trivial, dynamic partner of breast cancer cells

International Journal of Developmental Biology

Volumn 55, Issue 7-9, 2011, Pages 851-859

  Tan, Jinxiang ^a   Buache, Emilie ^a   Chenard, Marie Pierre ^b   Dali Youcef, Nassim ^a,c   Rio, Marie Christine ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Centre Hospitalier Universitaire de Hautepierre   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Adipocyte; Breast cancer; Diabetes; Metabolism; Obesity

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CCAAT ENHANCER BINDING PROTEIN ALPHA; COLLAGEN TYPE 4; CYCLIN D1; ESTROGEN RECEPTOR; HORMONE SENSITIVE LIPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN C FOS; RESISTIN; SOMATOMEDIN B; STROMELYSIN 2; STROMELYSIN 3; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SOX9;

ADIPOCYTE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER ASSOCIATED ADIPOCYTE; CANCER CELL; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL SHAPE; CELL TYPE; CELLULAR DISTRIBUTION; FIBROBLAST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; OBESITY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW;

ADIPOCYTES; ADIPOGENESIS; BREAST NEOPLASMS; CELL COMMUNICATION; DIABETES COMPLICATIONS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; NEOPLASM INVASIVENESS; OBESITY;

EID: 82555201367     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.113365jt     Document Type: Review

References (50)

1. ANDARAWEWA KL, RIO MC (2008). New insights into MMP function in adipogenesis. In The cancer degradome (Ed. DR Edwards), Springer Science, pp 353-364.
2. ANDARAWEWA KL, MOTRESCU ER, CHENARD MP, GANSMULLER A, STOLL I, TOMASETTO C, RIO MC (2005). Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 65: 10862-10871.
3. BASSET P, BELLOCQ JP, WOLF C, STOLL I, HUTIN P, LIMACHER JM, PODHAJCER OL, CHENARD MP, RIO MC, CHAMBON P (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704.
4. BEN SAHRA I, LE MARCHAND-BRUSTEL Y, TANTI JF, BOST F (2010). Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 9: 1092-1099.
5. CALLE EE, RODRIGUEZ C, WALKER-THURMOND K, THUN MJ (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638.
6. COOKE PS, NAAZ A (2004). Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) 229: 1127-1135.
7. DIRAT B, BOCHET L, DABEK M, DAVIAUD D, DAUVILLIER S, MAJED B, WANG YY, MEULLE A, SALLES B, LE GONIDEC S, GARRIDO I, ESCOURROU G, VALET P, MULLER C (2011). Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 71: 2455-2465.
8. DUGGAN C, IRWIN ML, XIAO L, HENDERSON KD, SMITH AW, BAUMGARTNER RN, BAUMGARTNER KB, BERNSTEIN L, BALLARD-BARBASH R, MCTIERNAN A (2010). Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29: 32-39.
9. EDWARDS PA (2000). The use of transplanted mammary gland to study cancer signalling pathways. Adv Exp Med Biol 480: 163-167.
10. ELLIOTT BE, TAM SP, DEXTER D, CHEN ZQ (1992). Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int J Cancer 51: 416-424.
11. FAIR AM, MONTGOMERY K (2009). Energy balance, physical activity, and cancer risk. Methods Mol Biol 472: 57-88.
12. FISCHER-POSOVSZKY P, WABITSCH M, HOCHBERG Z (2007). Endocrinology of adipose tissue-an update. Horm Metab Res 39: 314-321.
13. GOUVERI E, PAPANAS N, MALTEZOS E (2011). The female breast and diabetes. The breast 20: 205-211.
14. GREGOIRE FM (2001). Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood) 226: 997-1002.
15. GUILHERME A, VIRBASIUS JV, PURI V, CZECH MP (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
16. HOENE M, WEIGERT C (2008). The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 9: 20-29.
17. HOVEY RC, AIMO L (2010). Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia 15: 279-290.
18. IYENGAR P, COMBS TP, SHAH SJ, GOUON-EVANS V, POLLARD JW, ALBANESE C, FLANAGAN L, TENNISWOOD MP, GUHA C, LISANTI MP, PESTELL RG, SCHERER PE (2003). Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22: 6408-6423.
19. IYENGAR P, ESPINA V, WILLIAMS TW, LIN Y, BERRY D, JELICKS LA, LEE H, TEMPLE K, GRAVES R, POLLARD J, CHOPRA N, RUSSELL RG, SASISEKHARAN R, TROCK BJ, LIPPMAN M, CALVERT VS, PETRICOIN EF, 3RD, LIOTTA L, DADACHOVA E, PESTELL RG, LISANTI MP, BONALDO P, SCHERER PE (2005). Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 115: 1163-1176.
20. JODELE S, BLAVIER L, YOON JM, DECLERCK YA (2006). Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25: 35-43.
21. KAMAT A, HINSHELWOOD MM, MURRY BA, MENDELSON CR (2002). mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 13: 122-128.
22. KAUR T, ZHANG ZF (2005). Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev 6: 547-552.
23. KESSENBROCK K, PLAKS V, WERB Z (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67.
24. KIM JH, KIM KY, JEON JH, LEE SH, HWANG JE, LEE JH, KIM KK, LIM JS, KIM KI, MOON EY, LEE HG, RYU JH, YANG Y (2008). Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells. Cancer Lett 261: 253-262.
25. KIMIJIMA I, OHTAKE T, SAGARA H, WATANABE T, TAKENOSHITA S (2000). Scattered fat invasion: an indicator for poor prognosis in premenopausal, and for positive estrogen receptor in postmenopausal breast cancer patients. Oncology 59 Suppl 1: 25-30.
26. LE TT, HUFF TB, CHENG JX (2009). Coherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis. BMC Cancer 9: 42.
27. LEFEBVRE O, WOLF C, LIMACHER JM, HUTIN P, WENDLING C, LEMEUR M, BASSET P, RIO MC (1992). The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol 119: 997-1002.
28. MACEDO LF, SABNIS G, BRODIE A (2009). Aromatase inhibitors and breast cancer. Ann N Y Acad Sci 1155: 162-173.
29. MAEDA K, OKUBO K, SHIMOMURA I, MIZUNO K, MATSUZAWA Y, MATSUBARA K (1997). Analysis of an expression profile of genes in the human adipose tissue. Gene 190: 227-235.
30. MAJED B, MOREAU T, SENOUCI K, SALMON RJ, FOURQUET A, ASSELAIN B (2008). Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111: 329-342.
31. MALIN A, MATTHEWS CE, SHU XO, CAI H, DAI Q, JIN F, GAO YT, ZHENG W (2005). Energy balance and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 1496-1501.
32. MANABE Y, TODA S, MIYAZAKI K, SUGIHARA H (2003). Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 201: 221-228.
33. MENENDEZ JA, LUPU R (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777.
34. MIYOSHI Y, FUNAHASHI T, TANAKA S, TAGUCHI T, TAMAKI Y, SHIMOMURA I, NOGUCHI S (2006). High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118: 1414-1419.
35. MOTRESCU ER, RIO MC (2008). Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle. Biol Chem 389: 1037-1041.
36. MOTRESCU ER, BLAISE S, ETIQUE N, MESSADDEQ N, CHENARD MP, STOLL I, TOMASETTO C, RIO MC (2008). Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene 27: 6347-6355.
37. NAKAJIMA I, MUROYA S, TANABE R, CHIKUNI K (2002). Positive effect of collagen V and VI on triglyceride accumulation during differentiation in cultures of bovine intramuscular adipocytes. Differentiation 70: 84-91.
38. NOMURA DK, LONG JZ, NIESSEN S, HOOVER HS, NG SW, CRAVATT BF (2010). Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140: 49-61.
39. POLLAK M (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8: 915-928.
40. RABE K, LEHRKE M, PARHOFER KG, BROEDL UC (2008). Adipokines and insulin resistance. Mol Med 14: 741-751.
41. RIO MC (2011). The role of Cancer-Associated Adipocytes (CAA) in the dynamic interaction between the tumor and the host: Springer SBM.
42. RONNOV-JESSEN L, PETERSEN OW, KOTELIANSKY VE, BISSELL MJ (1995). The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 95: 859-873.
43. ROSE DP, VONA-DAVIS L (2009). Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther 9: 1091-1101.
44. SCHAFFLER A, SCHOLMERICH J, BUECHLER C (2007). Mechanisms of disease: adipokines and breast cancer-endocrine and paracrine mechanisms that connect adiposity and breast cancer. Nat Clin Pract Endocrinol Metab 3: 345-354.
45. SICLARI VA, GUISE TA, CHIRGWIN JM (2006). Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 25: 621-633.
46. VAINIO H, KAAKS R, BIANCHINI F (2002). Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev 11 Suppl 2:S94-100.
47. WALTER M, LIANG S, GHOSH S, HORNSBY PJ, LI R (2009). Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28: 2745-2755.
48. WANG CS, TETU B (2002). Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction. Int J Cancer 99: 792-799.
49. WEISBERG SP, MCCANN D, DESAI M, ROSENBAUM M, LEIBEL RL, FERRANTE AW, JR. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
50. YAMAGUCHI J, OHTANI H, NAKAMURA K, SHIMOKAWA I, KANEMATSU T (2008). Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast. Am J Clin Pathol 130: 382-388.